Press release from Companies: Curasight publishes information memorandum in connection with forthcoming rights issue

Press release from Companies: Annual Report for the fiscal year 2023

Reports: Year-end report October – December 2023

Reports: Year-end report October – December 2023

Press release from Companies: Curasight resolves on a rights issue of up to DKK 51.2 million to accelerate its therapeutic strategy

Press release from Companies: Curasight announces acceleration of therapeutic strategy to strengthen position as a radiopharmaceutical theranostic company

Press release from Companies: Curasight A/S Achieves First Milestone under collaboration with Curium Inc.

Press release from Companies: Curasight A/S submits clinical trial application (CTA) for phase 2 trial with uTRACE[®] in prostate cancer patients

Press release from Companies: Curasight A/S appoints CRO to run Phase 2 study with uTRACE[®] in prostate cancer

Press release from Companies: Curasight to present at HC Andersen Capital and Stokk.io

Reports: Interim Report January – September 2023

Press release from Companies: Curasight A/S reports positive preclinical results with uTREAT[®] in lung cancer (NSCLC)